 |
|
|
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
Dec '08 |
|
| Sales Turnover |
490.55 |
505.05 |
617.38 |
657.18 |
710.16 |
| Other Income |
11.99 |
4.88 |
4.24 |
35.32 |
37.11 |
| Total Income |
502.54 |
509.92 |
621.62 |
692.50 |
747.27 |
| Total Expenses |
336.99 |
368.34 |
455.25 |
498.92 |
523.99 |
| Operating Profit |
153.56 |
136.71 |
162.13 |
158.26 |
186.17 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-64.13 |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
165.55 |
141.59 |
166.37 |
193.58 |
223.28 |
| Interest |
1.75 |
0.77 |
5.44 |
2.01 |
4.04 |
| PBDT |
163.80 |
140.81 |
160.94 |
191.57 |
155.11 |
| Depreciation |
12.72 |
17.03 |
40.77 |
51.65 |
55.03 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
151.08 |
123.78 |
120.17 |
139.92 |
100.08 |
| Tax |
11.89 |
22.73 |
9.11 |
5.47 |
12.43 |
| Net Profit |
139.19 |
101.05 |
111.06 |
134.45 |
87.65 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
13.92 |
10.11 |
11.11 |
13.44 |
4.38 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
50.00 |
50.00 |
50.00 |
50.00 |
100.00 |
| Reserves |
631.67 |
747.61 |
869.39 |
1,274.69 |
-- |
| Face Value |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
|
|
|
| Source : Religare Technova |
| Explore Biocon connections |
|
